Dr. Agarwal's Health Care Limited
Dr. Agarwal's Health Care Limited (AGARWALEYE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
dragarwals.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 431 Cr | 460 Cr | 487 Cr | 499 Cr | 530 Cr | 564 Cr | 614 Cr |
| Operating expenses (approx.) | 316 Cr | 329 Cr | 360 Cr | 363 Cr | 386 Cr | 403 Cr | 444 Cr |
| EBITDA | 115 Cr | 131 Cr | 128 Cr | 136 Cr | 144 Cr | 161 Cr | 170 Cr |
| OPM % | 26.7% | 28.5% | 26.2% | 27.3% | 27.2% | 28.6% | 27.8% |
| Other income | 13 Cr | 15 Cr | 13 Cr | 8 Cr | 11 Cr | 13 Cr | 6 Cr |
| Interest | 28 Cr | 25 Cr | 25 Cr | 23 Cr | 21 Cr | 22 Cr | 23 Cr |
| Depreciation | 58 Cr | 60 Cr | 63 Cr | 68 Cr | 69 Cr | 77 Cr | 78 Cr |
| Profit before tax | 41 Cr | 59 Cr | 54 Cr | 54 Cr | 65 Cr | 77 Cr | 75 Cr |
| Tax % | 31.1% | 27.3% | 29.0% | 32.0% | 32.6% | 34.8% | 26.8% |
| Net profit | 28 Cr | 43 Cr | 38 Cr | 36 Cr | 44 Cr | 50 Cr | 55 Cr |
| EPS (₹) | ₹0.73 | ₹1.04 | ₹0.95 | ₹0.94 | ₹1.07 | ₹1.25 | ₹1.43 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 1,711 Cr | 2,080 Cr | Sign in for TTM |
| Operating expenses (approx.) | 1,255 Cr | 1,511 Cr | Sign in for TTM |
| EBITDA | 456 Cr | 570 Cr | Sign in for TTM |
| OPM % | 26.7% | 27.4% | Sign in for TTM |
| Other income | 46 Cr | 44 Cr | Sign in for TTM |
| Interest | 109 Cr | 90 Cr | Sign in for TTM |
| Depreciation | 231 Cr | 276 Cr | Sign in for TTM |
| Profit before tax | 160 Cr | 249 Cr | Sign in for TTM |
| Tax % | 31.0% | 32.4% | Sign in for TTM |
| Net profit | 110 Cr | 168 Cr | Sign in for TTM |
| EPS (₹) | ₹2.80 | ₹4.21 | Sign in for TTM |
| Dividend payout % | 0.7% | 0.6% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 32 Cr | 32 Cr |
| Reserves | 1,835 Cr | 1,994 Cr |
| Borrowings | 247 Cr | 157 Cr |
| Other liabilities | 1,498 Cr | 1,665 Cr |
| Total liabilities | 3,672 Cr | 3,942 Cr |
| Fixed assets (net) | 708 Cr | 926 Cr |
| CWIP | 144 Cr | 234 Cr |
| Investments | 264 Cr | 152 Cr |
| Inventories | 80 Cr | 94 Cr |
| Trade receivables | 124 Cr | 161 Cr |
| Cash & bank | 104 Cr | 91 Cr |
| Other assets | 2,249 Cr | 2,283 Cr |
| Total assets | 3,672 Cr | 3,942 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 360 Cr | 519 Cr |
| Cash from investing | -750 Cr | -308 Cr |
| Cash from financing | 382 Cr | -220 Cr |
| Net cash flow | -8 Cr | -10 Cr |
| Free cash flow (OCF − Capex) | 39 Cr | 58 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 12.4% | 14.9% |
| ROE % | 4.3% | 6.3% |
| Debtor days | 26 | 28 |
| Inventory days | 24761 | 39799 |
| Days payable | 47212 | 63175 |
| Cash conversion cycle | -22424 | -23348 |
| Debt / equity | 0.13 | 0.08 |
| Current ratio | 1.66 | 1.24 |
| Net debt / EBITDA | 0.31 | 0.12 |
Compare with peers
Loading peers…